47.85

1.77% 0.83

Pulse Biosciences Inc (PLSE)

Overview News Price History Option Chain Financials Discussions Forecast

Pulse Biosciences Inc stock is traded at $47.85, with a volume of 238.53K. It is up +1.77% in the last 24 hours and up +65.23% over the past month. Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

Previous Close:

$47.02

Open:

$46.76

24h Volume:

238.53K

Relative Volume:

0.64

Market Cap:

$3.41B

Revenue:

$751.00K

Net Income/Loss:

$-74.57M

P/E Ratio:

-43.38

EPS:

-1.1031

Net Cash Flow:

$-55.52M

1W Performance:

+6.52%

1M Performance:

+65.23%

6M Performance:

+123.39%

1Y Performance:

+200.00%

1-Day Range:

$46.64

$48.58

1-Week Range:

$42.70

$48.84

52-Week Range:

$12.56

$48.84

Pulse Biosciences Inc Stock (PLSE) Company Profile

Name

Pulse Biosciences Inc

Sector

Healthcare (1077)

Industry

Medical Instruments & Supplies (56)

Phone

510-906-4600

Address

3957 POINT EDEN WAY, HAYWARD, CA

Employee

116

Twitter

@PulseBioNPS

Next Earnings Date

2026-08-06

Latest SEC Filings

PLSE's Discussions on Twitter

Compare PLSE vs ISRG, BDX, ALC, RMD, MDLN

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PLSE Pulse Biosciences Inc	47.85	3.35B	751.00K	-74.57M	-55.52M	-1.1031
ISRG Intuitive Surgical Inc	374.48	140.51B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	187.62	51.10B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	72.93	35.90B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	228.44	33.27B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	32.58	29.75B	29.14B	1.07B	1.05B	1.1956

Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-30-26	Initiated	Mizuho	Outperform
Jul-07-25	Initiated	Oppenheimer	Outperform
Jul-27-21	Initiated	Stephens	Overweight
Mar-11-21	Initiated	Maxim Group	Buy
Jan-26-21	Reiterated	H.C. Wainwright	Buy
May-12-20	Upgrade	H.C. Wainwright	Neutral → Buy
Feb-14-20	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-25-19	Initiated	H.C. Wainwright	Buy

View All

Pulse Biosciences Inc Stock (PLSE) Latest News

Aug 20, 2026

Pulse (PLSE) Results Review: EPS Clears the Reported Estimate; Trading Move: Shares Rise 2.22% in the Latest ReadingDividend Growth Analysis - Vinanet

Aug 20, 2026

Bank of America Corp DE Grows Stake in Pulse Biosciences, Inc $PLSE - MarketBeat

Aug 20, 2026

Aug 19, 2026

Pulse Biosciences (PLSE) Launched A $75 Million Offering, Is The Upside Already Priced In? - Sahm

Aug 19, 2026

Pulse Biosciences (NASDAQ:PLSE) Sets New 1-Year HighHere's Why - MarketBeat

Aug 19, 2026

Aug 18, 2026

Pulse (PLSE) Earnings Review: EPS Exceeds Its Estimate in the Current Update; Reaction Snapshot - Vinanet

Aug 18, 2026

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 18, 2026 - BioSpace

Aug 18, 2026

Pulse Biosciences (PLSE) Grants Equity Awards to New Hires Amid High Price-to-Sales Valuation - GuruFocus

Aug 18, 2026

This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Sahm

Aug 18, 2026

Aug 17, 2026

This Okta Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday - Benzinga

Aug 17, 2026

Pulse Biosciences, Inc (NASDAQ:PLSE) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Aug 17, 2026

Needham & Company LLC Initiates Coverage on Pulse Biosciences (NASDAQ:PLSE) - MarketBeat

Aug 17, 2026

PLSE Initiates Coverage On by Needham -- Price Target Announced at $58.00 - GuruFocus

Aug 17, 2026

Needham initiates Pulse Biosciences stock with buy on ablation tech By Investing.com - Investing.com Canada

Aug 17, 2026

Needham Initiates Pulse Biosciences at Buy With $58 Price Target - marketscreener.com

Aug 17, 2026

Aug 16, 2026

PULSE BIOSCIENCES INC : NEEDHAM INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $58 - Bitget

Aug 16, 2026

Pulse Biosciences (PLSE) Is Up 5.0% After Wider Losses And $75M ATM Plan Filed – Has The Bull Case Changed? - simplywall.st

Aug 16, 2026

Pulse Biosciences (PLSE) Stock Looks Pricey On Book Value Yet Strong On Returns - Yahoo Finance

Aug 16, 2026

Pulse Biosciences Eyes AFib Breakthrough With Nanosecond PFA Platform - marketbeat.com

Aug 16, 2026

(PLSE) Risk Channels and Responsive Allocation - Stock Traders Daily

Aug 16, 2026

Pulse Biosciences (PLSE) Prices A $75 Million Offering, Is The Stock Fully Valued? - Yahoo Finance

Aug 16, 2026

Aug 14, 2026

PLSE Virtual Meeting on Strategic Initiatives Highlights Growth Expectations Despite High Valuation - GuruFocus

Aug 14, 2026

Aug 13, 2026

Pulse Biosciences stock reaches all-time high at 46.03 USD By Investing.com - Investing.com Australia

Aug 13, 2026

Pulse Biosciences stock reaches all-time high at 46.03 USD - Investing.com

Aug 13, 2026

$Pulse Biosciences (PLSE.US)$ SQUEEZING THE SHORTIES - Moomoo

Aug 13, 2026

Aug 11, 2026

Pulse Biosciences at Canaccord Genuity conference: nsPFA push gains pace By Investing.com - Investing.com Canada

Aug 11, 2026

PLSE: nsPFA technology delivers breakthrough efficacy in AFib and is poised for broad clinical adoption - TradingView

Aug 11, 2026